Germline CDH1 deletions in hereditary diffuse gastric cancer families

Human Molecular Genetics

Volumn 18, Issue 9, 2009, Pages 1545-1555

  Oliveira, Carla ^a,b   Senz, Janine ^c   Kaurah, Pardeep ^c   Pinheiro, Hugo ^a   Sanges, Remo ^d   Haegert, Anne ^e   Corso, Giovanni ^f   Schouten, Jan ^g   Fitzgerald, Rebecca ^h   Vogelsang, Holger ⁱ   Keller, Gisela ⁱ   Dwerryhouse, Sarah ^j   Grimmer, Donna ^k   Chin, Suet Feung ^k   Yang, Han Kwang ^l   Jackson, Charles E ^m   Seruca, Raquel ^a,b   Roviello, Franco ^f   Stupka, Elia ^d   Caldas, Carlos ^j,k   Huntsman, David ^c   more..

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d CBM Scrl   (Italy)

^e Prostate Centre Microarray Facility   (Canada)

^f UNIVERSITY OF SIENA   (Italy)

^g MRC HOLLAND   (Netherlands)

^h HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^l Seoul National University College of Medicine   (South Korea)

^m HENRY FORD HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; UVOMORULIN;

ARTICLE; CANCER INCIDENCE; CANCER RISK; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER MODEL; EXON; FAMILIAL CANCER; FRAMESHIFT MUTATION; GENE DELETION; GENE LOCUS; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; HUMAN CELL; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

ADULT; BASE SEQUENCE; CADHERINS; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEDIGREE; POINT MUTATION; SEQUENCE DELETION; STOMACH NEOPLASMS;

EID: 64549109715     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp046     Document Type: Article

References (47)

1. Lynch, H.T., Kaurah, P., Wirtzfeld, D., Rubinstein, W.S., Weissman, S., Lynch, J.F., Grady, W., Wiyrick, S., Senz, J. and Huntsman, D.G. (2008) Hereditary diffuse gastric cancer: Diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer, 112, 2655-2663.
2. Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A. and Reeve, A.E. (1998) E-cadherin germline mutations in familial gastric cancer. Nature, 392, 402-405.
3. Gayther, S.A., Gorringe, K.L., Ramus, S.J., Huntsman, D., Roviello, F., Grehan, N., Machado, J.C., Pinto, E., Seruca, R., Halling, K. et al. (1998) Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res., 58, 4086-4089.
4. Oliveira, C., Seruca, R. and Carneiro, F. (2006) Genetics, pathology, and clinics of familial gastric cancer. Int. J. Surg. Pathol., 14, 21-33.
5. Pharoah, P.D., Guilford, P. and Caldas, C.International Gastric Cancer Linkage Consortium (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology, 121, 1348-1353.
6. Kaurah, P., MacMillan, A., Boyd, N., Senz, J., De Luca, A., Chun, N., Suriano, G., Zaor, S., Van Manen, L., Gilpin, C. et al. (2007) Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA, 297, 2360-2372.
7. Huntsman, D.G., Carneiro, F., Lewis, F.R., MacLeod, P.M., Hayashi, A., Monaghan, K.G., Maung, R., Seruca, R., Jackson, C.E. and Caldas, C. (2001) Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N. Engl. J. Med., 344, 1904-1909.
8. Chun, Y.S., Lindor, N.M., Smyrk, T.C., Petersen, B.T., Burgart, L.J., Guilford, P.J. and Donohue, J.H. (2001) Germline E-cadherin gene mutations: Is prophylactic total gastrectomy indicated? Cancer, 92, 181-187.
9. Caldas, C., Carneiro, F., Lynch, H.T., Yokota, J., Wiesner, G.L., Powell, S.M., Lewis, F.R., Huntsman, D.G., Pharoah, P.D., Jankowski, J.A. et al. (1999) Familial gastric cancer: Overview and guidelines for management. J. Med. Genet., 36, 873-880.
10. Brooks-Wilson, A.R., Kaurah, P., Suriano, G., Leach, S., Senz, J., Grehan, N., Butterfield, Y.S., Jeyes, J., Schinas, J., Bacani, J. et al. (2004) Germline E-cadherin mutations in hereditary diffuse gastric cancer: Assessment of 42 new families and review of genetic screening criteria. J. Med. Genet., 41, 508-517.
11. Suriano, G., Yew, S., Ferreira, P., Senz, J., Kaurah, P., Ford, J.M., Longacre, T.A., Norton, J.A., Chun, N., Young, S. et al. (2005) Characterization of a recurrent germ line mutation of the E-cadherin gene: Implications for genetic testing and clinical management. Clin. Cancer Res., 11, 5401-5419.
12. Keller, G., Vogelsang, H., Becker, I., Plaschke, S., Ott, K., Suriano, G., Mateus, A.R., Seruca, R., Biedermann, K., Huntsman, D. et al. (2004) Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J. Med. Genet., 41, e89.
13. Oliveira, C., Ferreira, P., Nabais, S., Campos, L., Ferreira, A., Cirnes, L., Alves, C.C., Veiga, I., Fragoso, M., Regateiro, F. et al. (2004) E-Cadherin (CDH1) and TP53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur. J. Cancer 40, 1897-1903.
14. Biedermann, K., Vogelsang, H., Becker, I., Plaschke, S., Siewert, J.R., Höfler, H. and Keller, G. (2005) Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J. Pathol., 207, 199-206.
15. Nakagawa, H., Hampel, H. and de la Chapelle, A. (2003) Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques. Hum. Mutat., 22, 258.
16. Wijnen, J., van der Klift, H., Vasen, H., Khan, P.M., Menko, F., Tops, C., Meijers Heijboer, H., Lindhout, D., Moller, P. and Fodde, R. (1998) MSH2 genomic deletions are a frequent cause of HNPCC. Nat. Genet., 20, 326-328.
17. Charbonnier, F., Olschwang, S., Wang, Q., Boisson, C., Martin, C., Buisine, M.P., Puisieux, A. and Frebourg, T. (2002) MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res., 62, 848-853.
18. Baudhuin, L.M., Ferber, M.J., Winters, J.L., Steenblock, K.J., Swanson, R.L., French, A.J., Butz, M.L. and Thibodeau, S.N. (2005) Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. Gastroenterology, 129, 846-854.
19. Michils, G., Tejpar, S., Thoelen, R., van Cutsem, E., Vermeesch, J.R., Fryns, J.P., Legius, E. and Matthijs, G. (2005) Large deletions of the APC Gene in 15% of mutation-negative patients with classical polyposis (FAP): A Belgian study. Hum. Mutat., 25, 125-134.
20. Thomassen, M., Gerdes, A.M., Cruger, D., Jensen, P.K. and Kruse, T.A. (2006) Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. Cancer Genet. Cytogenet., 168, 168-171.
21. Knappskog, S., Geisler, J., Arnesen, T., Lillehaug, J.R. and Lønning, P.E. (2006) A Novel Type of Deletion in the CDKN2A Gene Identified in a Melanoma-Prone Family. Genes Chrom. Cancer, 45, 1155-1163.
22. Venturin, M., Gervasini, C., Orzan, F., Bentivegna, A., Corrado, L., Colapietro, P., Friso, A., Tenconi, R., Upadhyaya, M., Larizza, L. et al. (2004) Evidence for non-homologous end joining and non-allelic homologous recombination in atypical NF1 microdeletions. Hum. Genet. 115, 69-80.
23. Matejas, V., Huehne, K., Thiel, C., Sommer, C., Jakubiczka, S. and Rautenstrauss, B. (2006) Identification of Alu elements mediating a partial PMP22deletion. Neurogenetics, 7, 119-126.
24. Ramsden, D.A., McBlane, J.F., van Gent, D.C. and Gellert, M. (1996) Distinct DNA sequence and structure requirements for the two steps of V(D)J recombination signal cleavage. EMBO J., 15, 3197-3206.
25. Lewis, S.M., Agard, E., Suh, S. and Czyzyk, L. (1997) Cryptic signals and the fidelity of V(D)J joining. Mol. Cell. Biol., 17, 3125-3136.
26. Casilli, F., Tournier, I., Sinilnikova, O.M., Coulet, F., Soubrier, F., Houdayer, C., Hardouin, A., Berthet, P., Sobol, H., Bourdon, V. et al. (2006) The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J. Med. Genet., 43, e49.
27. Krawczak, M. and Cooper, D.N. (1991) Gene deletions causing human genetic disease: Mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum. Genet., 86, 425-441.
28. Pistorius, S., Görgens, H., Plaschke, J., Hoehl, R., Krüger, S., Engel, C., Saeger, H.D. and Schackert, H.K. (2007) Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett., 248, 89-95.
29. Chan, C.Y., Kiechle, M., Manivasakam, P. and Schiestl, R.H. (2007) Ionizing radiation and restriction enzymes induce microhomology-mediated illegitimate recombination in Saccharomyces cerevisiae. Nucleic Acids Res., 35, 5051-5059.
30. Lee, K. and Lee, S.E. (2007) Saccharomyces cerevisiae Sae2- and Tel1-dependent single-strand DNA formation at DNA break promotes microhomology-mediated end joining. Genetics, 176, 2003-2014.
31. Korbel, J.O., Urban, A.E., Affourtit, J.P., Godwin, B., Grubert, F., Simons, J.F., Kim, P.M., Palejev, D., Carriero, N.J., Du, L. et al. (2007) Paired-end mapping reveals extensive structural variation in the human genome. Science, 318, 420-426.
32. Perry, G.H., Ben-Dor, A., Tsalenko, A., Sampas, N., Rodriguez-Revenga, L., Tran, C.W., Scheffer, A., Steinfeld, I., Tsang, P., Yamada, N.A. et al. (2008) The fine-scale and complex architecture of human copy-number variation. Am. J. Hum. Genet., 82, 685-695.
33. Bonaglia, M.C., Giorda, R., Massagli, A., Galluzzi, R., Ciccone, R. and Zuffardi, O. (2008) A familial inverted duplication/deletion of 2p25.1-25.3 provides new clues on the genesis of inverted duplications. Eur. J. Hum. Genet. Epub ahead of print.
34. de Smith, A.J., Walters, R.G., Coin, L.J., Steinfeld, I., Yakhini, Z., Sladek, R., Froguel, P. and Blakemore, A.I. (2008) Small deletion variants have stable breakpoints commonly associated with alu elements. PLoS ONE, 3, e3104.
35. Elso, C., Lu, X., Morrison, S., Tarver, A., Thompson, H., Thurkow, H., Yamada, N.A. and Stubbs, L. (2008) Germline translocations in mice: unique tools for analyzing gene function and long-distance regulatory mechanisms. J. Natl Cancer Inst. Monogr., 39, 91-95.
36. Sprecher, E., Bergman, R., Richard, G., Lurie, R., Shalev, S., Petronius, D., Shalata, A., Anbinder, Y., Leibu, R., Perlman, I. et al. (2001) Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin. Nat. Genet., 29, 134-136.
37. Kjaer, K.W., Hansen, L., Schwabe, G.C., Marques-de-Faria, A.P., Eiberg, H., Mundlos, S., Tommerup, N. and Rosenberg, T. (2005) Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome). J. Med. Genet., 42, 292-298.
38. Oliveira, C., Bordin, M.C., Grehan, N., Huntsman, D., Suriano, G., Machado, J.C., Kiviluoto, T., Aaltonen, L., Jackson, C.E., Seruca, R. et al. (2002) Screening of E-Cadherin in gastric cancer families reveals germ-line mutations only in hereditary diffuse gastric cancer kindred. Hum. Mutat., 19, 510-517.
39. Oliveira, C., de Bruin, J., Nabais, S., Ligtenberg, M., Moutinho, C., Nagengast, F.M., Seruca, R., van Krieken, H. and Carneiro, F. (2004) Intragenic deletion of CDH-1 as the inactivating mechanism of the wild-type allele in a HDGC tumor. Oncogene, 23, 9192-9196.
40. Simões-Correia, J., Figueiredo, J., Oliveira, C., van Hengel, J., Seruca, R., van Roy, F. and Suriano, G. (2008) Endoplasmic reticulum quality control: A new mechanism of E-cadherin regulation and its implication in cancer. Hum. Mol. Genet., 17, 3566-3576.
41. Frebourg, T., Oliveira, C., Hochain, P., Karam, R., Manouvrier, S., Graziadio, C., Vekemans, M., Hartmann, A., Baert-Desurmont, S., Alexandre, C. et al. (2006) Cleft lip/palate and CDH1/ E-cadherin mutations in families with hereditary diffuse gastric cancer. J. Med. Genet., 43, 138-142.
42. Roviello, F., Corso, G., Pedrazzani, C., Marrelli, D., De Falco, G., Berardi, A., Garosi, L., Suriano, G., Vindigni, C., De Stefano, A. et al. (2007) Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur. J. Surg. Oncol., 33, 448-451.
43. Keller, G., Vogelsang, H., Becker, I., Hutter, J., Ott, K., Candidus, S., Grundei, T., Becker, K.F., Mueller, J., Siewert, J.R. et al. (1999) Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am. J. Pathol., 155, 337-342.
44. Barber, M., Murrell, A., Ito, Y., Maia, A.T., Hyland, S., Oliveira, C., Save, V., Carneiro, F., Paterson, A.L. and Grehan, N. (2008) Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J. Pathol., 216, 295-306.
45. Avizienyte, E., Launonen, V., Salovaara, R., Kiviluoto, T. and Aaltonen, L. (2001) E-cadherin is not frequently mutated in hereditary gastric cancer. J. Med. Genet., 38, 49-52.
46. Richards, F.M., McKee, S.A., Rajpar, M.H., Cole, T.R., Evans, D.G., Jankowski, J.A., McKeown, C., Sanders, D.S. and Maher, E.R. (1999) Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum. Mol. Genet., 8, 607-610.
47. Schouten, J.P., McElgunn, C.J., Waaijer, R., Zwijnenburg, D., Diepvens, F. and Pals, G. (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res., 30, e57.